Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma, With Randomization Depending on the Site of Relapse or on Previous Treatment

NCT04455139 is registered in ClinicalTrials.gov with Prof. Beck Popovic Maja as lead sponsor.

NCT NCT04455139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04455139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma, With Randomization Depending on the Site of Relapse or on Previous Treatment
Lead sponsor
Prof. Beck Popovic Maja
Phase
Phase 2
Overall status
Terminated
Start date
November 15, 2021
Completion date
May 22, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eye cancer, retinoblastoma